Medical research
-
Seven Rounds on Mechanism
Interferon, BAFF, germinal centres and the molecules built to interrupt them. Match, sort, order and spot…
-
Where the Primary Endpoint Went
Twenty years of trials, most of them negative, a few of them finally not. Twelve questions…
-
The Pipeline & the Miracles — RheumaPlay
Breakthrough designation, phase III, ‘approved in one country’, stem cells and gland regrowth. Seven rounds on…
-
DISH III · Complex cases · Clinical Rounds
Complex DISH decisions across trauma, airway and surgery; special populations, long-term care and critical appraisal of…
-
PsA research directions: what is changing and what remains open
A dated reading selection on tissue biology, new treatment designs, molecular prediction and interception. Each entry…
-
Reading PsA studies: endpoints, comparisons and meaningful benefit
Learn to translate a headline into a question you can examine: who was studied, what improved,…
-
PsA biomarkers: what tests can tell us—and what they cannot
A biomarker becomes useful when it answers a defined question. Distinguish a measure of inflammation from…
-
From psoriasis to PsA: risk, early signs and prevention
How to think about future arthritis without treating a risk factor as a diagnosis. The aim…
-
PsA mechanisms: tissues, immune signals and bone
Follow inflammation from the tissue where symptoms arise to the signals that targeted treatments interrupt. A…
-
RheumaView Ecosystem
A guide to my connected projects The RheumaView ecosystem Imaging, research, clinical challenges, and interactive learning…